Clormec plus, 1% ivermectina, 10% clorsulon, solução injectável para bovinos
Clormec plus, 1% ivermectina, 10% clorsulon, solução injectável para bovinos
Authorised
- Clorsulon
- Ivermectin
Product identification
Medicine name:
Clormec plus, 1% ivermectina, 10% clorsulon, solução injectável para bovinos
Active substance:
- Clorsulon
- Ivermectin
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clorsulon100.00/milligram(s)1.00millilitre(s)
-
Ivermectin10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal66dayNão utilizar em vacas lactantes produtoras de leite destinado ao consumo humano ou nos 28 dias que antecedem o parto
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 614/01/12NFVPT
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 12/08/2022